Kurser indlæses...
Prognose
Analytikernes gennemsnitlige kursmål er 23,59 € (-35,55 %). Medianen er 23,59 € (-35,55 %).
| Køb |
4 |
| Behold |
3 |
| Sælg |
0 |
Diskussioner i communityet
Der er endnu ingen diskussion om dette aktiv.
Start diskussionNyheder Til nyhedsfeedet
RELX: £1,000 investment 10 years ago would have returned +75.14%
Ten years ago RELX traded at £14.68; a £1,000 investment would have bought 68.12 shares. At a closing price of £25.71 on 06 October 2026 the holding would be worth £1,751.36, representing a performance of +75.14%. RELX’s market value is most recently quoted at £43.98 billion; calculation does not take stock splits or dividends into account. » Mere på finanzen.net
RELX announces share buyback of £125 million
RELX is launching a share buyback program worth £125 million, running from 7 September to 21 October 2026. The move follows a recently completed £150 million repurchase and is part of a 2026 plan totaling £2.25 billion. The aim is a capital reduction; the shares acquired will be held as treasury stock. J.P. Morgan Securities will lead the program and make trading decisions independently of the company; purchases will be made under the authority granted at the annual general meeting. » Mere på de.investing.com
RELX positioned to benefit from AI adoption in legal and risk products
Aoris Investment Management highlights RELX's proprietary content and analytics as increasingly valuable for AI-powered legal research, risk management and scientific tools. About one-third of revenue comes from scientific research tools, another third from risk solutions, 20% from legal content and 10% from exhibitions. RELX reports rapid uptake of its premium legal AI offering (roughly half of legal customers within 2.5 years) and sees 20–30% productivity gains in R&D, while its shares have fallen about 25% over the past year. » Mere på finance.yahoo.com
RELX: organic revenue +7% in first half, adjusted operating profit +9%
RELX reports organic revenue growth of seven percent in the first half to just under £4.9 billion and an adjusted operating profit that rose organically by nine percent to £1.7 billion. Revenue and operating profit were largely in line with analysts' expectations. CEO Erik Engstrom expects the positive trend to continue. The shares rose about three percent in early trading, reducing the year-to-date decline to around 16 percent. » Mere på finanzen.net
RELX launches £200 million share buyback
RELX has announced a £200 million share buyback programme that will run from 9 to 26 June 2026. The buyback follows a recently completed £150 million repurchase and is part of a 2026 programme totalling £2.25 billion. Purchased shares will be held as treasury stock; ABN AMRO will manage the programme independently on the basis of instructions. The buyback is being carried out under the authority granted at the annual general meeting on 23 April 2026 and is in accordance with UK and EU market abuse rules and the Listing Rules. » Mere på de.investing.com
Historisk udbytte Udbytte
Alle nøgletal for udbytte Alle nøgletalVirksomhedstal
| (EUR) | juni 2026 | YoY |
|---|---|---|
| Omsætning | 5,65 mia. | - |
| Bruttofortjeneste | 3,62 mia. | - |
| Nettoresultat | 1,36 mia. | - |
| EBITDA | 2,27 mia. | - |
Fundamentale data
| Nøgletal | Værdi |
|---|---|
Markedsværdi | 63,75 mia. € |
Antal aktier | 1,73 mia. |
Højeste/laveste i 52 uger | 39,33 € - 25,01 € |
Udbytteafkast | 2,19 % |
Udbytte TTM | 0,80 € |
Beta | 0,26 |
P/E (PE Ratio) | 24,36 |
PEG (PEG Ratio) | 1,15 |
K/I (PB Ratio) | 44,29 |
P/S (PS Ratio) | 5,48 |
Virksomhedsprofil
RELX PLC leverer informationsbaserede analyser og beslutningsværktøjer til professionelle og erhvervskunder i Nordamerika, Europa og internationalt. Virksomheden opererer gennem fire segmenter: Risk; Scientific, Technical & Medical; Legal; og Exhibitions. Risk-segmentet tilbyder informationsbaserede analyser og beslutningsværktøjer, der kombinerer offentligt tilgængeligt og brancherelateret indhold med teknologi og algoritmer for at hjælpe kunder med at vurdere og forudsige risiko. Scientific, Technical & Medical-segmentet leverer information og analyser, der hjælper institutioner og fagfolk med at skabe fremskridt inden for videnskab og fremme sundhedsvæsenet. Legal-segmentet leverer juridisk, regulatorisk og forretningsmæssig information og analyser, der hjælper kunder med beslutningstagning og øger produktiviteten. Exhibitions-segmentet er aktivt i eventbranchen, hvor det kombinerer fysiske møder med data og digitale værktøjer for at hjælpe kunder med at lære om markeder, finde produkter og gennemføre transaktioner. Virksomheden var tidligere kendt som Reed Elsevier PLC og skiftede navn til RELX PLC i juli 2015. Virksomheden blev stiftet i 1903 og har hovedkontor i London, Storbritannien.
| Navn | RELX PLC |
| CEO | Erik Engstrom |
| Hjemsted | London,
gl Storbritannien |
| Websted | |
| Sektor | Industrivirksomheder |
| Branche | Kommercielle tjenester og forsyninger |
| Børsnotering | 06.10.1994 |
| Medarbejdere | 37.000 |
Deep Dive
Tickersymboler
| Børs | Symbol |
|---|---|
NYSE | RELX |
Frankfurt | RDED.F |
München | RDED.MU |
Düsseldorf | RDED.DU |